Skip to content
PeptideSport
Revel Health logo

Provider review

Revel Health review

Pricing is shown openly on the homepage — no quiz-gating required

Revel Health combines GLP-1 weight loss with NAD+ and sermorelin longevity care, prescribed by board-certified physicians, confirmed live. Semaglutide runs from $199/mo ($99 the first month); tirzepatide from $249/mo ($149 first month); NAD+ from $169/mo; sermorelin from $149/mo — all shown openly on the homepage, confirmed live, correcting prior research's claim that cost is only learned at checkout. Its own site names 45 covered states, confirmed live, stating verbatim it "cannot currently serve patients in: AK, AR, NC, NJ or MS" — an exact match to prior research. A LegitScript badge with seal #46146639 appears on-site; the specific "USP 795/800" standard prior research cited isn't literally on the page, which instead uses general "USP-compliant" language. A 100% refund applies if a physician determines you're not a candidate.

Verified August 2026

Straight talk: how we earn — some, not all, of these are affiliate links; start a program through one and we may earn a commission at no extra cost to you. Straight about the rest, too: the write-ups say what each provider is actually worth, and a commission does not change a word of them. Full disclosure here.

On this page

The verdict

Revel Health is more transparent on pricing than prior research had credited it for — per-product rates are shown right on the homepage, not gated behind a quiz. Its 45-state coverage claim checks out exactly, with the same five exclusions prior research recorded. The main gap is the same one prior research flagged: the compounding pharmacy itself is still never individually named, just described in general USP-compliance language.

Revel Health is not ranked on any of our boards. This is a standalone read of what the company publishes about itself — the providers we do rank in this category are on our semaglutide provider ranking. Nothing on this page is a performance claim — see the evidence review for what these compounds do and do not do.

Who it is for, and who it is not

A good fit if

  • You want to see pricing before starting an intake, not after
  • You want GLP-1 combined with longevity add-ons (NAD+, sermorelin) on one platform
  • You want a fast physician review — typically within the hour, confirmed live

Look elsewhere if

  • You live in Alaska, Arkansas, North Carolina, New Jersey, or Mississippi — all confirmed excluded
  • You want a named compounding pharmacy rather than general USP-compliance language
  • You want brand-name GLP-1 options — this is compounded only

What it actually costs

What they advertise

Semaglutide: $99 the first month, confirmed live on myrevelhealth.com.

What you actually pay, month to month

$199/mo ongoing for semaglutide, $249/mo for tirzepatide, both confirmed live.

The commitment trap

The $99 first-month price isn't the ongoing rate; semaglutide steps up to $199/mo from month two.

Checked live on Revel Health's own site at https://myrevelhealth.com in August 2026. Prices change without notice — confirm before you buy. Work out what a vial actually gives you with our peptide dose calculator.

What is included

The cheapest headline number in this category is often the one with the least attached to it. Here is what Revel Health bundles in, and what it does not.

Clinician consult

Physician review, typically within the hour, confirmed live.

Bloodwork / labs

Not addressed in the sources read.

Follow-ups and dose changes

Not addressed with a specific cadence in the sources read.

Human support

Not addressed with specifics in the sources read.

Injection supplies

Included in the flat price, confirmed live.

Shipping

Included in the flat price, confirmed live.

Pharmacy, labs and oversight

The pharmacy

Described only as "USP-compliant pharmacies"; no specific name disclosed, confirmed live.

Oversight

Physician review, typically within the hour, confirmed live. Not addressed with a specific cadence in the sources read.

Compounded peptides are not FDA-approved products, and a 503A pharmacy compounds for a named patient while a 503B outsourcing facility manufactures in batches under CGMP. Neither is a quality guarantee on its own — a named facility is simply a fact you can check, and an unnamed “partner pharmacy network” is not. Our guide to verifying a certificate of analysis covers what to ask for.

Where you can get it

45 states; excludes Alaska, Arkansas, North Carolina, New Jersey, and Mississippi, confirmed live.

The honest cons

The part they would rather you skipped

Revel Health's LegitScript badge and general "USP-compliant" language are confirmed live, but the specific compounding pharmacy behind your medication is still never individually named anywhere on the site.

  • Compounding pharmacy never individually named
  • Excluded in 5 states (Alaska, Arkansas, North Carolina, New Jersey, Mississippi)
  • Longevity add-ons (NAD+, sermorelin) add cost beyond the core GLP-1 program
  • Compounded medications only — no brand-name option

None of this is unique to Revel Health — the whole category shares it. What we hold against a provider is the part it hides, and the ways vendors hide things are catalogued in our vendor red-flags guide.

How it compares

Read this before you buy

A provider comparison is half the decision. The other half is whether the compound does anything for you at all — and whether it is allowed where you compete. Growth-hormone secretagogues are banned in tested sport, year-round, and a prescription does not change that.

Facts on this page reflect Revel Health's own public disclosures when we last checked them, in August 2026. Prices and terms change without notice — confirm on Revel Health's site before you buy. Provider names and logos on this page identify the company under review; their use does not imply endorsement, sponsorship or affiliation. This page is informational and not medical advice; compounded peptides are not FDA-approved, and growth-hormone secretagogues are banned in tested sport year-round. See our disclosure and editorial policy.